A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes

Molecular Pharmacology

Volumn 78, Issue 2, 2010, Pages 287-296

  Moretti, Milena ^a   Mugnaini, Manolo ^b   Tessari, Michela ^b   Zoli, Michele ^c   Gaimarri, Annalisa ^a   Manfredi, Irene ^a   Pistillo, Francesco ^a   Clementi, Francesco ^a   Gotti, Cecilia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b GSK   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NEURONAL NICOTINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA4BETA2ALPHA5; NICOTINIC RECEPTOR ALPHA6BETA2; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; COMPARATIVE STUDY; DRUG EFFECT; DRUG INFUSION; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; STOICHIOMETRY; UPREGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BRAIN; IMMUNOPRECIPITATION; INFUSIONS, INTRAVENOUS; MALE; MOLECULAR SEQUENCE DATA; NEURONS; NICOTINE; RADIOLIGAND ASSAY; RATS; RECEPTORS, NICOTINIC; SELF ADMINISTRATION;

EID: 77954941134     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.064071     Document Type: Article

References (41)

1. Buisson B and Bertrand D (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23:130-136.
2. Doura MB, Gold AB, Keller AB, and Perry DC (2008) Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215:40-52.
3. Gaimarri A, Moretti M, Riganti L, Zanardi A, Clementi F, and Gotti C (2007) Regulation of neuronal nicotinic receptor traffic and expression. Brain Res Rev 55:134-143.
4. Gentry CL and Lukas RJ (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1:359-385.
5. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, and Zoli M (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703-711.
6. Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, et al. (2010) Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30:5311-5325.
7. Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, and Whiteaker P (2005a) Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. Mol Pharmacol 67:2007-2015.
8. Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, and Marks MJ (2008) Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol 73:1796-1807.
9. Gotti C, Moretti M, Zanardi A, Gaimarri A, Champtiaux N, Changeux JP, Whiteaker P, Marks MJ, Clementi F, and Zoli M (2005b) Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents. Mol Pharmacol 68:1162-1171.
10. Govind AP, Vezina P, and Green WN (2009) Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol 78:756-765.
11. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, and Gotti C (2009) Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. J Neurosci 29:2272-2282.
12. Klink R, de Kerchove d'Exaerde A, Zoli M, and Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452-1463.
13. Kuryatov A, Luo J, Cooper J, and Lindstrom J (2005) Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol 68:1839-1851.
14. Lai A, Parameswaran N, Khwaja M, Whiteaker P, Lindstrom JM, Fan H, McIntosh JM, Grady SR, and QuikM(2005) Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice. Mol Pharmacol 67:1639-1647. (Pubitemid 40594163)
15. Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, Banghart MR, Dougherty DA, Goate AM, and Wang JC (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J 11:167-177.
16. Livingstone PD and Wonnacott S (2009) Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochem Pharmacol 78:744-755.
17. Mao D, Perry DC, Yasuda RP, Wolfe BB, and Kellar KJ (2008) The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to upregulation by nicotine in vivo. J Neurochem 104:446-456.
18. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, and Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
19. Marks MJ, Whiteaker P, and Collins AC (2006) Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Mol Pharmacol 70:947-959.
20. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190:269-319.
21. Moroni M, Zwart R, Sher E, Cassels BK, and Bermudez I (2006) alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:755-768.
22. Mugnaini M, Garzotti M, Sartori I, Pilla M, Repeto P, Heidbreder CA, and Tessari M (2006) Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience 137:565-572.
23. Nashmi R and Lester H (2007) Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol 74:1145-1154.
24. Nelson ME, Kuryatov A, Choi CH, Zhou Y, and Lindstrom J (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol 63:332-341.
25. Nguyen HN, Rasmussen BA, and Perry DC (2004) Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J Neurochem 90:40-49.
26. Parker SL, Fu Y, McAllen K, Luo J, McIntosh JM, Lindstrom JM, and Sharp BM (2004) Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Mol Pharmacol 65:611-622.
27. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
28. Perry DC, Dávila-García MI, Stockmeier CA, and Kellar KJ (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289:1545-1552.
29. Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, and Kellar KJ (2007) Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322:306-315.
30. Picciotto MR, Addy NA, Mineur YS, and Brunzell DH (2008) It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84:329-342.
31. Rezvani K, Teng Y, Shim D, and De Biasi M (2007) Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J Neurosci 27:10508-10519.
32. Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, and Gotti C (2005) Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br J Pharmacol 146:1096-1109.
33. Rowell PP and Li M (1997) Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem 68:1982-1989. (Pubitemid 27176134)
34. Sallette J, Bohler S, Benoit P, Soudant M, Pons S, Le Novère N, Changeux JP, and Corringer PJ (2004) An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J Biol Chem 279:18767-18775.
35. Son CD, Moss FJ, Cohen BN, and Lester HA (2009) Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy. Mol Pharmacol 75:1137-1148.
36. Tumkosit P, Kuryatov A, Luo J, and Lindstrom J (2006) Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines. Mol Pharmacol 70:1358-1368.
37. Ulrich YM, Hargreaves KM, and Flores CM (1997) A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal 3H-epibatidine binding sites. Neuropharmacology 36:1119-1125.
38. Vallejo YF, Buisson B, Bertrand D, and Green WN (2005) Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 25:5563-5572.
39. Walsh H, Govind AP, Mastro R, Hoda JC, Bertrand D, Vallejo Y, and Green WN (2008) Up-regulation of nicotinic receptors by nicotine varies with receptor subtype. J Biol Chem 283:6022-6032.
40. Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, and Lester HA (2009) Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29:12428-12439.
41. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789.